- Cellcom Israel‘s net income for the third quarter of 2025 was 76 million shekels, marking a 36% increase compared to the same period last year.
- Revenue for the same quarter fell by 7.4% to 1.03 billion shekels.
- The average revenue per mobile user decreased by 6.6% to 40.80 shekels.
- Cellcom Israel shares saw a rise of 2.5%, reaching a price of 3,553 Israeli shekels.
- Total shares traded amounted to 191,642 during this period.
- Current analyst recommendations include 1 buy, 0 holds, and 2 sells.
A look at Cellcom Israel Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 1 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Cellcom Israel, a major player in the cellular communications industry, possesses a promising long-term outlook based on a comprehensive analysis of its various aspects. With a strong momentum score of 5, the company demonstrates robust performance indicators signaling positive growth potential. This is further supported by a growth score of 4, indicating favorable prospects for expansion and development in the future. Additionally, the company’s value and resilience scores of 3 each suggest a stable foundation and reasonable valuation, contributing to its overall positive outlook.
Despite these strengths, Cellcom Israel‘s dividend score of 1 highlights a relatively lower focus on dividend payouts compared to other factors. However, the company’s solid performance in areas such as momentum, growth, value, and resilience underscores its positioning for long-term success in the competitive telecommunications sector. With a diversified portfolio of services, including cellular, landline telephony, internet, and data offerings, Cellcom Israel remains a key player in the industry, continuously striving towards innovation and customer satisfaction.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
